hematoxylin has been researched along with Sarcoma, Endometrial Stromal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baak, JP; Dalen, I; Feng, W; Gudlaugsson, E; Hua, K; Malpica, A; Robboy, SJ; Skaland, I; Zhou, X | 1 |
1 other study(ies) available for hematoxylin and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?
Topics: Adult; Biomarkers, Tumor; Cell Proliferation; Endometrial Neoplasms; Eosine Yellowish-(YS); Female; Hematoxylin; Histones; Humans; Hysterectomy; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Mitotic Index; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Sarcoma, Endometrial Stromal; Survival Analysis; World Health Organization | 2013 |